Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.130
-0.020 (-1.74%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Entera Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-11.44-9.54-8.89-13.07-12.19
Upgrade
Depreciation & Amortization
0.030.050.060.060.05
Upgrade
Stock-Based Compensation
2.752.561.692.251.86
Upgrade
Other Operating Activities
0.030.010.030.1-0.2
Upgrade
Change in Accounts Receivable
0.13-0.130.25-0.060.07
Upgrade
Change in Accounts Payable
0.320.050.07-0.150
Upgrade
Change in Unearned Revenue
----0.02-0.14
Upgrade
Change in Other Net Operating Assets
0.820.19-0.51-1.611.48
Upgrade
Operating Cash Flow
-7.37-6.82-7.31-12.5-9.06
Upgrade
Capital Expenditures
-0.11-0-0.02-0.05-0.02
Upgrade
Other Investing Activities
----0.06-
Upgrade
Investing Cash Flow
-0.11-0-0.02-0.1-0.02
Upgrade
Issuance of Common Stock
13.974.86.620.0125.38
Upgrade
Other Financing Activities
-0.26-0.32-0.58--
Upgrade
Financing Cash Flow
13.714.486.040.0125.38
Upgrade
Foreign Exchange Rate Adjustments
0.04----
Upgrade
Net Cash Flow
6.27-2.35-1.29-12.5916.3
Upgrade
Free Cash Flow
-7.48-6.82-7.33-12.55-9.08
Upgrade
Free Cash Flow Margin
-17802.38%-3768.51%--9362.69%-1590.19%
Upgrade
Free Cash Flow Per Share
-0.16-0.18-0.25-0.44-0.35
Upgrade
Cash Income Tax Paid
---0.170
Upgrade
Levered Free Cash Flow
-11.44-3.42-3.82-7.99-4.33
Upgrade
Unlevered Free Cash Flow
-11.44-3.42-3.82-7.99-4.33
Upgrade
Change in Working Capital
1.260.11-0.2-1.841.41
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.